Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation

1 Mar 1998

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer-related Molecular Pathways
Share to Cancer Research and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 9514057
DOI: 10.1038/bjc.1998.126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablationPMID 9514057Read ↗

Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinomaSemantic proximity Read ↗

Targeting p53 Dysfunction in Hepatocellular Carcinoma: Translational Barriers and Opportunities for AI-Driven Precision MedicineSemantic proximity Read ↗

Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular CarcinomaSemantic proximity Read ↗

Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?Semantic proximity Read ↗

[p53 mutations as prognostic factors of hepatocellular carcinomas].Semantic proximity Read ↗

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

p53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.Semantic proximity Read ↗

Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposureSemantic proximity Read ↗

Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: a p53 Research Group study.Semantic proximity Read ↗

p16INK4A gene alterations are not a prognostic indicator for survival in patients with hepatocellular carcinoma undergoing curative hepatectomy.Semantic proximity Read ↗

Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?Semantic proximity Read ↗

Prognosis of hepatocellular carcinoma in hemodialysis patients treated with radiofrequency ablation: a retrospective, single-center cohort study with propensity-score matchingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.